Global Antimicrobial Susceptibility Testing Product Market Size By Type (Automated Laboratory Instruments, Manual Antimicrobial Susceptibility Testing Products), By Application (Clinical Diagnostics,...

The Global Antimicrobial Susceptibility Testing (AST) Product Market was valued at USD 4.2 billion in 2023 and is projected to reach USD 7.6 billion by 2031, expanding at a CAGR of 7.4% during the forecast period from 2023 to 2031. The market is primarily driven by the rising prevalence of antimicrobial resistance (AMR), growing awareness regarding appropriate antibiotic use, and increasing investment in diagnostic infrastructure. The demand for AST products is growing rapidly across hospitals, clinical laboratories, and pharmaceutical companies due to the urgent need for accurate and timely diagnosis to combat resistant microbial strains.

Drivers:

1. Rising Global Burden of Antimicrobial Resistance (AMR):

The alarming rate at which bacteria and other microbes are becoming resistant to standard treatments is one of the most significant public health concerns globally. This trend is fueling the adoption of AST products to support evidence-based prescribing.

2. Government and Regulatory Initiatives:

Governments and global health organizations are implementing stringent regulations and funding programs to promote antibiotic stewardship and support diagnostic testing, accelerating the growth of AST technologies.

3. Technological Advancements in Microbiology:

Modernization in AST technologies—such as automated and rapid testing systems, microfluidics, and AI integration—has improved accuracy, reduced time-to-results, and enhanced workflow efficiency, making these solutions more appealing across healthcare settings.

Restraints:

1. High Cost of Advanced AST Systems:

Automated and rapid susceptibility testing instruments entail high initial investments and maintenance costs, which may hinder adoption in resource-limited settings or small laboratories.

2. Lack of Standardization Across Testing Platforms:

Variability in test procedures and interpretation standards among different manufacturers can lead to inconsistencies, affecting clinical decision-making and limiting broader adoption.

Opportunity:

1. Emerging Markets and Decentralized Diagnostics:

With healthcare infrastructure improving across Asia-Pacific, Latin America, and Africa, there's a growing opportunity for AST product penetration. The rise of point-of-care testing and decentralized diagnostic models further expands the market scope.

2. Personalized Medicine and Pharma R&D:

The rise of personalized antimicrobial therapy and increasing use of AST in pharmaceutical drug discovery pipelines are opening new avenues for growth, especially in the area of novel drug-resistance detection technologies.

Market by System Type Insights:

In 2023, the Automated AST Systems segment accounted for the largest market share. These systems are increasingly adopted in hospital and clinical labs due to their speed, high-throughput capabilities, and reduced dependency on skilled microbiologists. Meanwhile, the Rapid AST Systems segment is projected to witness the fastest growth, driven by the demand for faster diagnosis in critical care settings and emergency departments.

Market by End-Use Insights:

The Hospitals & Diagnostic Laboratories segment dominated the market in 2023, accounting for over 45% of global revenue. This dominance is attributed to the high patient volume, the need for timely treatment decisions, and the presence of structured microbiology departments. However, Pharmaceutical and Biotechnology Companies are emerging as a key end-user segment, leveraging AST in antimicrobial drug development and clinical trial workflows.

Market by Regional Insights:

North America led the global AST product market in 2023, supported by advanced healthcare infrastructure, robust diagnostic networks, and high awareness of antimicrobial resistance. Asia-Pacific is expected to register the highest CAGR during the forecast period, driven by rising investments in healthcare, increasing incidence of infectious diseases, and growing public-private partnerships in diagnostics.

Competitive Scenario:

Key players in the Global Antimicrobial Susceptibility Testing Product Market include bioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bruker Corporation, HiMedia Laboratories, and Accelerate Diagnostics Inc. These companies are investing in R&D, strategic acquisitions, and geographic expansions to strengthen their market positions.

Key Market Developments:

2023: bioMérieux launched its next-gen automated AST system featuring AI-based result interpretation and cloud-based reporting integration.

2024: Thermo Fisher Scientific announced a partnership with a leading diagnostic network in India to expand its reach in emerging markets.

2025: Accelerate Diagnostics introduced a portable AST device aimed at critical care units and point-of-care applications.

Scope of Work – Global Antimicrobial Susceptibility Testing Product Market

Report Metric Details

Market Size (2023) USD 4.2 billion

Projected Market Size (2031) USD 7.6 billion

CAGR (2023–2031) 7.4%

Market Segments By System Type (Automated, Manual, Rapid), End-use (Hospitals, Diagnostic Labs, Pharma)

Growth Drivers Rising AMR, Government Policies, Diagnostic Modernization

Opportunities Expansion in Emerging Markets, Personalized Therapy Applications

FAQs:

1) What is the current market size of the Global Antimicrobial Susceptibility Testing Product Market?

The market size was valued at USD 4.2 billion in 2023.

2) What is the major growth driver of the Global Antimicrobial Susceptibility Testing Product Market?

The primary driver is the rising burden of antimicrobial resistance (AMR) and the growing need for precision diagnostics.

3) Which is the largest region during the forecast period in the Global Antimicrobial Susceptibility Testing Product Market?

North America leads the market, though Asia-Pacific is expected to grow at the fastest rate.

4) Which segment accounted for the largest market share in the Global Antimicrobial Susceptibility Testing Product Market?

The Automated AST Systems segment held the largest share in 2023.

5) Who are the key market players in the Global Antimicrobial Susceptibility Testing Product Market?

Key players include bioMérieux SA, Becton Dickinson, Thermo Fisher Scientific, Danaher Corporation, and Accelerate Diagnostics Inc.